
Corteva and Arevo Partner on Soy Crop Nutrition
GlobeNewsWire
公開日時: Jul 03, 2026, 02:00 PM
Sentiment Analysis
Corteva and Arevo Partner on Soy Crop Nutrition The partnership will help farmers in Europe improve nutrient use efficiency July 03, 2026 10:00 ET | Source: Arevo Arevo UMEÅ, July 03, 2026 (GLOBE NEWSWIRE) -- Corteva, a global pure-play agriculture company, and Arevo, a Swedish science-led crop nutrition company, have announced a partnership on Arginex Soy, Arevo’s seed applied crop nutrition system.
Arginex Soy is an innovative arginine 1 -based seed treatment designed to strengthen root systems, increase nodulation and improve soybean performance, offering growers a new way to boost yields and crop resilience while advancing more sustainable production practices. In soybeans, arginine helps stimulate the growth of root hairs, which are important for the formation of nodules where beneficial nitrogen-fixing bacteria take hold. This helps strengthen the plant’s natural ability to fix nitrogen and supports healthier root development and more efficient nutrient use from the earliest stages of growth.
Corteva is integrating the product, which is already available to farmers in Europe, into its soybean seed treatment portfolio to help get crops off to the best start. The agreement follows a multi-stage technical evaluation assessing agronomic performance, formulation stability, and operational compatibility with Corteva’s existing soybean seed treatment portfolio. The evaluation confirmed that Arginex Soy can deliver measurable crop performance benefits while fitting seamlessly into existing seed treatment processes, reducing barriers to adoption and enabling growers to access the technology through established commercial channels.
Leonardo Costa, EMEA Seed Applied Technologies Leader, Corteva Agriscience, said: “Rigorous evaluation has confirmed that Arginex Soy delivers the consistency and formulation stability required for Corteva’s se...
Source: GlobeNewsWire
個別の投資に関する推奨やアドバイスを提供することを意図しておりません。ここで述べられている意見や見解は、あくまでも各記事の個人的見解です。